Breo Ellipta InhalationBREO ELLIPTA is a combination of fluticasone furoate, an inhaled corticosteroid (ICS), and vilanterol, a long-acting beta2-adrenergic agonist (LABA), indicated for long-term, once-daily, maintenance treatment of airflow obstruction and for reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).
Use Breo Ellipta inhalation powder exactly as prescribed by your doctor. Follow all directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended. The usual dose of this medicine is 1 inhalation per day. Use the medicine at the same time each day, and not more than once in a 24-hour period. Tell your doctor if any of your medicines seem to stop working as well in controlling your COPD. Breo Ellipta is a powder that comes with a special inhaler device preloaded with blister packs containing measured doses of the medicine. The device opens and loads a blister of Breo Ellipta each time you use the inhaler. The disk device is not to be used with a spacer. Follow the patient instructions provided with the inhaler device.
DO NOT USE BREO ELLIPTA: • If patient has a severe allergy to milk proteins. • If patient is allergic to fluticasone furoate & vilanterol. • In children. It is not known if BREO ELLIPTA is safe and effective in children. • To treat sudden symptoms of COPD. • For the treatment of asthma. .
Runny nose and sore throat
Upper respiratory tract infection
Thrush in the mouth and or throat. Rinse your mouth without swallowing after use to help prevent this.
Product Code: 13156
What is a Generic Drug?
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.